Analyst Ratings
Upgrades, downgrades, and price-target changes from Wall Street firms.
Jones Trading Reiterates Buy Rating on Tyra Biosciences
Jones Trading reaffirms its buy rating on Tyra Biosciences with a $56 price target.
Raymond James Reiterates Buy Rating for Janus Living, Inc.
Raymond James maintains its buy rating for Janus Living, Inc. with a $34 price target.
JP Morgan Upgrades The Macerich Company to 'Hold'
JP Morgan's analyst raised the rating for The Macerich Company to 'hold' with a new price target of $25.
Raymond James Upgrades CareTrust REIT to Buy
Raymond James reinstates CareTrust REIT with a buy rating and a $43 price target.
Raymond James Upgrades Healthcare Realty Trust to 'Buy'
Raymond James raised its rating on Healthcare Realty Trust, setting a new price target.
JP Morgan Downgrades Rexford Industrial Realty to Sell
JP Morgan's Michael Mueller lowers Rexford's rating to sell with a $36 target.
Raymond James Boosts Omega Healthcare Investors, Inc. Rating to 'Buy'
Raymond James reinstated its buy rating for Omega Healthcare Investors, Inc., with a $50 target.
TD Cowen Reiterates Buy Rating on Axsome Therapeutics, Inc.
TD Cowen maintains its buy rating on Axsome Therapeutics with a $300 price target.
B of A Securities Reiterates Buy Rating on CSX Corporation
Analyst Ken Hoexter maintains a buy rating on CSX with a $53 target.
Needham Reiterates Buy Rating on ServiceTitan, Inc. (TTAN)
Needham keeps a buy rating on ServiceTitan with a target price of $100.
HC Wainwright Reaffirms Buy Rating for IRD
HC Wainwright maintains a buy rating on IRD, targeting $8 per share.
Goldman Sachs Upgrades Allegiant Travel Company to Buy
Goldman Sachs has reinstated Allegiant Travel Company with a Buy rating and a $125 price target.
Goldman Sachs Downgrades ZGN to Hold, Sets Price Target at $14
Goldman Sachs has downgraded ZGN's rating to hold and set a new price target of $14.
Chardan Capital Reiterates Buy Rating for SAB Biotherapeutics
Chardan Capital keeps its buy rating on SAB Biotherapeutics with a $16 price target.
Morgan Stanley Downgrades ResMed Inc. to Hold
Morgan Stanley has lowered its rating on ResMed Inc. to hold with a new price target of $230.
Bernstein Reiterates Buy Rating for Delta Air Lines
Bernstein maintains its buy rating for Delta Air Lines, setting a price target of $93.
Morgan Stanley Upgrades Credicorp Ltd. to 'Buy'
Morgan Stanley raises Credicorp's target price to $480, signaling confidence.
Morgan Stanley Upgrades Charles River Laboratories to Buy
Morgan Stanley has raised its rating on Charles River Laboratories to Buy with a $220 target.
Morgan Stanley Downgrades IQVIA Holdings to Hold
Morgan Stanley lowered its rating on IQVIA Holdings to hold with a $200 price target.
Baird Reiterates Buy Rating for Landstar System, Inc.
Baird maintains its buy rating on Landstar System, Inc. with a $225 price target.
Baird Reiterates Buy Rating on Ryder System, Inc.
Baird maintains its buy rating for Ryder System, Inc. with a new price target of $290.
Baird Reiterates Buy Rating on SNDR
Baird maintains its bullish stance on SNDR with a $39 price target.
Baird Reiterates Buy Rating for Lionsgate Studios
Baird maintains a buy rating on Lionsgate Studios with a $20 price target.
B of A Securities Downgrades LDOS to Hold, Sets $125 Target
B of A Securities lowered its rating for LDOS to 'hold' with a target price of $125.